2016-03-11T00:00:00.000-05:00
A-623 targets,0.3271
ready program,0.272532
State Teachers Retirement,0.308271
Elevated levels,-0.762167
chronic diseases,-0.816548
clinical-stage programs,0.272532
Anthera Pharmaceuticals,-0.314153
research analysts,0.209122
acute inflammatory conditions,-0.762167
consensus price target,0.469183
acute coronary syndrome,-0.730173
coronary artery disease,-0.816548
Zacks Investment Research‘s,0.643743
InvestorPlace Broker Center,0.555736
systemic lupus erythematosus,-0.359076
biopharmaceutical company,-0.373953
Friday,-0.312944
California State Teachers,0.308271
Zacks Investment Research,0.320408
personal trading style,0.598412
target price,0.319786
Pharmaceuticals Inc Daily,0.397938
buy rating,0.209122
autoimmune diseases,-0.541375
B-lymphocyte stimulator,0.3271
acute chest syndrome,-0.730173
average price,0.329286
company’s stock,0.319786
nephropathy lupus nephritis,-0.336113
concise daily summary,0.505807
Marketbeat reports,-0.22006
previous close,0.643743
candidate blisibimod targets,0.446563
mid-day trading,-0.312944
potential upside,0.643743
quarterly earnings data,-0.310056
